Organ-on-Chip Market to Reach $163.1 Million by 2025

  • Published: March 2018

Global organ-on-chip market size is forecasted to reach $163.1 million by 2025, according to P&S Intelligence.

The growth in the market will be led by the rising need for effective drug discovery and development, increasing demand for alternatives for animal models in research, increasing drug repurposing approaches, and government grants and funds for research.

Insights on market segments

The organ-on-chip market has been categorized into product and services, on the basis of offering by the market players. The products are expected to register faster growth in demand, registering a CAGR of 43.8% during the forecast period, due to the advancement in research leading to arrangement of newer organs cells on chips.

In terms of type, the organ-on-chip market has been categorized as liver-on-chip, lung-on-chip, kidney-on-chip, heart-on-chip, intestine-on-chip, brain-on-chip, and others. Among these, liver-on-chip held the largest share in the global organ-on-chip market, in 2017. The increasing prevalence of chronic liver diseases, and advancement in research for its therapeutic intervention are the key factors for the largest share of the category.

Browse report overview with 40 tables and 41 figures spread through 111 pages and detailed TOC on "Organ-on-Chip Market by Offering (Services, Products), by Type (Liver-on-Chip, Lung-on-Chip, Kidney-on-Chip, Heart-on-Chip, Intestine-on-Chip, Brain-on-Chip), by Application (Toxicology Research, Physiological Model Development, Drug Discovery), by End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes), by Geography (U.S., Canada, Germany, U.K., France, China, Japan) – Global Market Size, Share, Development, Growth and Demand Forecast, 2016–2025" at:

Organ-on-chip products find application in toxicology research, physiological model development, and drug discovery. The application of organ-on-chip for drug discovery is projected to witness fastest growth in demand, registering CAGR of 47.7% during the forecast period. On the basis of end user, the adoption of organ-on-chip by pharmaceutical and biotechnology companies is higher as compared to academic & research institutes, and other end users since a majority of grants and investments for research and development are received by these companies.

Asia-Pacific (APAC) to exhibit fastest growth with CAGR of 48.1%

The organ-on-chip market in APAC is expected to witness a significant growth during the forecast period. This growth is attributed to factors such as increasing healthcare expenditure, rising government initiatives and funding for healthcare R&D, and increase in the adoption of advanced technologies in the region.

There are many ongoing research to determine the potential of organ-on-chip as a new platform for biological analysis, funded by government organisations such as Chinese Academy of Sciences, and the National Key Scientific Instrument and Equipment Development Project, China. These factors will drive the growth of the APAC organ-on-Chip market in the future.

Major players are launching innovative products to gain a larger market share

The players in organ-on-chip market are launching new and innovative products to enhance their product portfolio. For instance, in July 2017, Hmrel Corporation, launched HuRELviral application. The Hµrelviral microliver testing platform sustains hepatitis B virus (HBV) infection in actual human liver cells for over thirty days. This is expected to equip virologists with unprecedented insight into a drug candidate’s potential to cure chronic HBV.

Furthermore, in February 2017, InSphero AG introduced the GravityTRAP 384 Microtissue Platform at the Society for Laboratory Automation and Screening (SLAS) 2017 Conference. The GravityTRAP 384 platform features distinct microtissue culture and media chambers separated by a tapered SureXchange pipetting ledge, and a continuous flat-bottomed glass base plate combined with a black-walled body, ensuring superior confocal and high content imaging optics while reducing fluorescent cross-talk between wells.

Some of the other key players operating in the organ-on-chip industry include Emulate Inc., Mimetas B.V., TissUse GmbH, Kirkstall Ltd., CN Bio Innovations Ltd, Ascendance Biotechnology, Inc., Nortis, Inc., and Organovo Holdings, Inc.


By Offering

  • Services
  • Products

By Type

  • Liver-on-Chip
  • Lung-on-Chip
  • Kidney-on-Chip
  • Heart-on-Chip
  • Intestine-on-Chip
  • Brain-on-Chip
  • Others

By Application

  • Toxicology Research
  • Physiological Model Development
  • Drug Discovery

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • Others

By Region

  • North America organ-on-chip market
    • By offering
    • By type
    • By application
    • By end user
    • By country - U.S., Canada
  • Europe organ-on-chip market
    • By offering
    • By type
    • By application
    • By end user
    • By country – Germany, U.K., France and Rest of Europe
  • APAC organ-on-chip market
    • By offering
    • By type
    • By application
    • By end user
    • By country – China, Japan, Rest of APAC
  • Rest of the World (RoW) organ-on-chip market
    • By offering
    • By type
    • By application
    • By end user